These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The possibilities and pitfalls for anti-complement therapies in inflammatory diseases. Mizuno M; Morgan BP Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):87-96. PubMed ID: 15032645 [TBL] [Abstract][Full Text] [Related]
3. Controlling the complement system in inflammation. Kirschfink M Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114 [TBL] [Abstract][Full Text] [Related]
4. Complement therapeutics; history and current progress. Morgan BP; Harris CL Mol Immunol; 2003 Sep; 40(2-4):159-70. PubMed ID: 12914822 [TBL] [Abstract][Full Text] [Related]
5. Targeting complement in therapy. Kirschfink M Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360 [TBL] [Abstract][Full Text] [Related]
6. Development of complement therapeutics for inhibition of immune-mediated red cell destruction. Yazdanbakhsh K Transfusion; 2005 Aug; 45(2 Suppl):122S-9S. PubMed ID: 16086799 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic inhibition of the complement system. Y2K update. Asghar SS; Pasch MC Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868 [TBL] [Abstract][Full Text] [Related]
8. [Clinical applications of recombinant complement inhibitors]. Lipiński D; Pławski A; Juzwa W; Zeyland J; Słomski R Pol Merkur Lekarski; 2004 Jun; 16(96):571-5. PubMed ID: 15510900 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological manipulation of the complement system in human diseases. Asghar SS Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241 [TBL] [Abstract][Full Text] [Related]
16. Tailoring anti-complement therapeutics. Harris CL; Fraser DA; Morgan BP Biochem Soc Trans; 2002 Nov; 30(Pt 6):1019-26. PubMed ID: 12440965 [TBL] [Abstract][Full Text] [Related]
17. Membrane-targeted complement inhibitors. Smith GP; Smith RA Mol Immunol; 2001 Aug; 38(2-3):249-55. PubMed ID: 11532286 [TBL] [Abstract][Full Text] [Related]
18. Complement: the Iceman of immunology? Würzner R Immunopharmacology; 1997 Dec; 38(1-2):63-4. PubMed ID: 9476115 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future. Risitano AM; Marotta S Semin Immunol; 2016 Jun; 28(3):223-40. PubMed ID: 27346521 [TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the complement system currently in development for cardiovascular disease. Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]